Outcome of Frontline Treatment with "Generic" Imatinib In Adult Patients with Chronic Myeloid Leukemia in Algerian Population: A Multicenter Study.

Entasoltan B, Bekadja MA, Touhami H, Mehalhal N, Zouaoui Z, Mesli N, Talbi M, Bachiri A, Michallet M

DOI: 10.4084/mjhid.2017.062
Published: 2017
Container: Mediterranean journal of hematology and infectious diseases
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.4084/mjhid.2017.062,
  title = {Outcome of Frontline Treatment with "Generic" Imatinib In Adult Patients with Chronic Myeloid Leukemia in Algerian Population: A Multicenter Study.},
  author = {Entasoltan B and Bekadja MA and Touhami H and Mehalhal N and Zouaoui Z and Mesli N and Talbi M and Bachiri A and Michallet M},
  year = {2017},
  journal = {Mediterranean journal of hematology and infectious diseases},
  doi = {10.4084/mjhid.2017.062},
  url = {https://doi.org/10.4084/mjhid.2017.062}
}

RIS

TY  - JOUR
TI  - Outcome of Frontline Treatment with "Generic" Imatinib In Adult Patients with Chronic Myeloid Leukemia in Algerian Population: A Multicenter Study.
AU  - Entasoltan B
AU  - Bekadja MA
AU  - Touhami H
AU  - Mehalhal N
AU  - Zouaoui Z
AU  - Mesli N
AU  - Talbi M
AU  - Bachiri A
AU  - Michallet M
PY  - 2017
JO  - Mediterranean journal of hematology and infectious diseases
DO  - 10.4084/mjhid.2017.062
UR  - https://doi.org/10.4084/mjhid.2017.062
ER  -

APA

B, E., MA, B., H, T., N, M., Z, Z., N, M., M, T., A, B., & M, M. (2017). Outcome of Frontline Treatment with "Generic" Imatinib In Adult Patients with Chronic Myeloid Leukemia in Algerian Population: A Multicenter Study.. Mediterranean journal of hematology and infectious diseases. https://doi.org/10.4084/mjhid.2017.062

Source records

pubmed · retrieved 2026-09-26T05:00:48.511Z